User profiles for Susanne Bäck

Susanne Bäck

Senior Scientist, R&D Therapy Area CNS, Disease Biology - Neurodegeneration, Orion …
Verified email at orionpharma.com
Cited by 1153

Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease

MH Voutilainen, S Bäck, E Pörsti… - Journal of …, 2009 - Soc Neuroscience
Neurotrophic factors are promising candidates for the treatment of Parkinson's disease (PD).
Mesencephalic astrocyte-derived neurotrophic factor (MANF) belongs to a novel …

Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease

MH Voutilainen, S Bäck, J Peränen, P Lindholm… - Experimental …, 2011 - Elsevier
Cerebral dopamine neurotrophic factor (CDNF) and mesencephalic astrocyte-derived
neurotrophic factor (MANF) constitute a novel, evolutionarily conserved family of neurotrophic …

Gene therapy with AAV 2‐CDNF provides functional benefits in a rat model of P arkinson's disease

S Bäck, J Peränen, E Galli, P Pulkkila… - Brain and …, 2013 - Wiley Online Library
Cerebral dopamine neurotrophic factor ( CDNF ) protein has been shown to protect the
nigrostriatal dopaminergic pathway when given as intrastriatal infusions in rat and mouse models …

[PDF][PDF] KDEL receptors are differentially regulated to maintain the ER proteome under calcium deficiency

KA Trychta, S Bäck, MJ Henderson, BK Harvey - Cell reports, 2018 - cell.com
Retention of critical endoplasmic reticulum (ER) luminal proteins needed to carry out diverse
functions (eg, protein synthesis and folding, lipid metabolism) is mediated through a carboxy…

[PDF][PDF] Neuron-specific genome modification in the adult rat brain using CRISPR-Cas9 transgenic rats

S Bäck, J Necarsulmer, LR Whitaker, LM Coke… - Neuron, 2019 - cell.com
Historically, the rat has been the preferred animal model for behavioral studies. Limitations
in genome modification have, however, caused a lag in their use compared to the bevy of …

Update of neurotrophic factors in neurobiology of addiction and future directions

M Koskela, S Bäck, V Võikar, CT Richie… - Neurobiology of …, 2017 - Elsevier
Drug addiction is a chronic brain disease and drugs of abuse cause long lasting
neuroadaptations. Addiction is characterized by the loss of control over drug use despite harmful …

Evidence for an additive neurorestorative effect of simultaneously administered CDNF and GDNF in hemiparkinsonian rats: implications for different mechanism of …

MH Voutilainen, F De Lorenzo, P Stepanova, S Bäck… - Eneuro, 2017 - eneuro.org
Parkinson’s disease (PD) is a neurodegenerative disorder associated with a progressive
loss of dopaminergic (DAergic) neurons of the substantia nigra (SN) and the accumulation of …

High fat diet disrupts endoplasmic reticulum calcium homeostasis in the rat liver

ES Wires, KA Trychta, S Bäck, A Sulima, KC Rice… - Journal of …, 2017 - Elsevier
Background & Aims Disruption to endoplasmic reticulum (ER) calcium homeostasis has been
implicated in obesity, however, the ability to longitudinally monitor ER calcium fluctuations …

[HTML][HTML] Pre-α-pro-GDNF and pre-β-pro-GDNF isoforms are neuroprotective in the 6-hydroxydopamine rat model of Parkinson's disease

…, MH Voutilainen, M Koskela, S Bäck… - Frontiers in …, 2018 - frontiersin.org
Glial cell line-derived neurotrophic factor (GDNF) is one of the most studied neurotrophic
factors. GDNF has two splice isoforms, full-length pre-α-pro-GDNF (α-GDNF) and pre-β-pro-…

[PDF][PDF] A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome

MJ Henderson, KA Trychta, SM Yang, S Bäck… - Cell reports, 2021 - cell.com
Endoplasmic reticulum (ER) dysregulation is associated with pathologies including
neurodegenerative, muscular, and diabetic conditions. Depletion of ER calcium can lead to the loss …